Comments
The All India Biotech Association – Southern Chapter (AIBA-SC) has come out strongly in favour of the Indian Patents Office order in favour of Natco Pharma Ltd.
In a statement, Dr B.S. Bajaj, Chairman of the Association said: “Bayer has no ground to challenge the order issued by the Patent Controller of India since it is in the interest of 1.2 billion Indian people and in accordance with the TRIPS agreement provision for compulsory license signed by our country”.
The association has criticised Bayer for not agreeing to the “fair decision”.
soma@thehindu.co.in
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.